ask="14.40"
ask_size="200"
average_daily_volume="178667"
bid="13.30"
bid_size="200"
book_value="3.69"
change="+0.30"
change_from_200_day_moving_average="3.24"
change_from_50_day_moving_average="0.90"
change_from_52_week_high="-1.40"
change_From_52_week_low="9.32"
change_in_percent="+2.33%"
close="13.20"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.17"
ebitda="-38.95M"
eps_estimate_current_year="-2.14"
eps_estimate_next_quarter="-0.53"
eps_estimate_next_year="-1.88"
ex_dividend_date="N/A"
float_shares="15630000"
high="13.30"
high_52_weeks="14.60"
last_trade_date="1/9/2017"
last_trade_price="13.20"
last_trade_size="7453"
last_trade_time="4:00pm"
low="12.45"
low_52_weeks="3.88"
market_capitalization="235.57M"
moving_average_200_day="9.96"
moving_average_50_day="12.30"
name="Stemline Therapeutics
Inc."
notes="N/A"
one_year_target_price="29.25"
open="13.20"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+32.48%"
percent_change_from_50_day_moving_average="+7.29%"
percent_change_from_52_week_high="-9.59%"
percent_change_from_52_week_low="+240.21%"
previous_close="12.90"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="3.50"
price_per_sales="242.94"
revenue="947604.00"
shares_outstanding="17846000"
short_ratio="6.77"
stock_exchange="NCM"
symbol="STML"
volume="248283"
weeks_range_52="3.88 - 14.60"
